Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Growth

    Back to All Ratios
LACTOSE (INDIA) is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 66.33-5.7996.48-31.65-4.68

What is the latest Core EBITDA Growth ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Growth ratio of LACTOSE (INDIA) is 66.33 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202466.33
Mar2023-5.79
Mar202296.48
Mar2021-31.65
Mar2020-4.68

How is Core EBITDA Growth of LACTOSE (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 66.33
Positive
Mar2023 -5.79
Negative
Mar2022 96.48
Positive
Mar2021 -31.65
Negative
Mar2020 -4.68 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Growth ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹159.5 Cr 6.3% 31.6% -19.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,370.0 Cr 1% -0.2% -13.4% Stock Analytics
DIVIS LABORATORIES ₹160,087.0 Cr -2.7% -2.2% 17.6% Stock Analytics
CIPLA ₹126,308.0 Cr -1.7% 4.1% -5.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,614.0 Cr 1% 1.3% 4.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,845.0 Cr 2.5% 7.7% -6.7% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

6.3%

31.6%

-19.1%

SENSEX

1.1%

1%

-0.9%


You may also like the below Video Courses